SVAAX | VIVIX | SVAAX / VIVIX | |
Total Expense Ratio | 1.06 | 0.04 | 2,650% |
Annual Report Gross Expense Ratio | 1.17 | 0.04 | 2,925% |
Fund Existence | 21 years | 27 years | - |
Gain YTD | 11.766 | 9.748 | 121% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.67B | 208B | 4% |
Annual Yield % from dividends | 2.99 | 2.09 | 143% |
Returns for 1 year | 4.72 | 4.64 | 102% |
Returns for 3 years | 28.61 | 42.98 | 67% |
Returns for 5 years | 64.22 | 71.78 | 89% |
Returns for 10 years | 42.94 | 129.40 | 33% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNCX | 63.20 | 0.38 | +0.60% |
Janus Henderson Global Life Sciences C | |||
GMVRX | 16.40 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity R | |||
VDVIX | 15.09 | 0.01 | +0.07% |
Vanguard Developed Markets Index Inv | |||
FDCPX | 135.32 | N/A | N/A |
Fidelity Select Tech Hardware | |||
BUISX | 15.00 | -0.04 | -0.27% |
Buffalo Small Cap Growth Institutional |